Literature DB >> 16919267

Functional implication of truncated P-cadherin expression in malignant melanoma.

Richard Bauer1, Anja Katrin Bosserhoff.   

Abstract

Cadherins comprise Ca(2+)-dependent homophilic cell-cell adhesion molecules which are responsible for correct location of cells and for tissue integrity. They are crucial factors for the development and maintenance of epithelial architecture. Aberrantly expressed cadherins are known to be involved in malignant transformation of different types of tissues. In a previous study, we determined the expression of a short truncated 50 kDa form of P-cadherin only consisting of the N-terminal part in malignant melanoma. Further analysis revealed that this short 50 kDa form of P-cadherin representing the N-terminal, extracellular region, is secreted by melanoma cells in contrast to the membrane bound form in melanocytes. In order to define the functional relevance of expression of the 50 kDa P-cadherin variant in malignant melanoma, antisense P-cadherin cell clones were generated. The clones in which P-cadherin expression is reduced show no changes in proliferation or in attachment-independent growth when compared to controls. However, a strong reduction of migratory and invasive properties was observed in these cells, suggesting that truncated P-cadherin promotes melanoma cell invasion and migration and therefore has an important role in the progression of malignant melanoma. Functionally, the secreted form of P-cadherin could play a role as regulator of the homophilic interaction between P-cadherin molecules by antagonizing their biological role acting as a dominant negative form to interrupt cell-cell attachment.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16919267     DOI: 10.1016/j.yexmp.2006.07.002

Source DB:  PubMed          Journal:  Exp Mol Pathol        ISSN: 0014-4800            Impact factor:   3.362


  4 in total

1.  X-linked protocadherin 19 mutations cause female-limited epilepsy and cognitive impairment.

Authors:  Leanne M Dibbens; Patrick S Tarpey; Kim Hynes; Marta A Bayly; Ingrid E Scheffer; Raffaella Smith; Jamee Bomar; Edwina Sutton; Lucianne Vandeleur; Cheryl Shoubridge; Sarah Edkins; Samantha J Turner; Claire Stevens; Sarah O'Meara; Calli Tofts; Syd Barthorpe; Gemma Buck; Jennifer Cole; Kelly Halliday; David Jones; Rebecca Lee; Mark Madison; Tatiana Mironenko; Jennifer Varian; Sofie West; Sara Widaa; Paul Wray; John Teague; Ed Dicks; Adam Butler; Andrew Menzies; Andrew Jenkinson; Rebecca Shepherd; James F Gusella; Zaid Afawi; Aziz Mazarib; Miriam Y Neufeld; Sara Kivity; Dorit Lev; Tally Lerman-Sagie; Amos D Korczyn; Christopher P Derry; Grant R Sutherland; Kathryn Friend; Marie Shaw; Mark Corbett; Hyung-Goo Kim; Daniel H Geschwind; Paul Thomas; Eric Haan; Stephen Ryan; Shane McKee; Samuel F Berkovic; P Andrew Futreal; Michael R Stratton; John C Mulley; Jozef Gécz
Journal:  Nat Genet       Date:  2008-05-11       Impact factor: 38.330

2.  Prognostic significance of cadherin-based adhesion molecules in cutaneous malignant melanoma.

Authors:  Gretchen M Kreizenbeck; Aaron J Berger; Antonio Subtil; David L Rimm; Bonnie E Gould Rothberg
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2008-04       Impact factor: 4.254

3.  The epidermal polarity protein Par3 is a non-cell autonomous suppressor of malignant melanoma.

Authors:  Melina Mescher; Peter Jeong; Sina K Knapp; Matthias Rübsam; Michael Saynisch; Marina Kranen; Jennifer Landsberg; Max Schlaak; Cornelia Mauch; Thomas Tüting; Carien M Niessen; Sandra Iden
Journal:  J Exp Med       Date:  2017-01-17       Impact factor: 14.307

4.  Microarray-based cancer prediction using soft computing approach.

Authors:  Xiaosheng Wang; Osamu Gotoh
Journal:  Cancer Inform       Date:  2009-05-26
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.